Participation in adjuvant clinical breast cancer trials: Does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 553-563

  Schwentner, L ^a   Van Ewijk, R ^b   Kurzeder, C ^c   Hoffmann, I ^b   Konig J ^b   Kreienberg, R ^a   Blettner, M ^b   Wockel A ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Breast cancer; Guideline adherence; Study participation; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GONADORELIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; PATIENT PARTICIPATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84872680151     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.08.011     Document Type: Article

References (25)

1. S. Badve, D.J. Dabbs, and S.J. Schnitt Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Mod Pathol 24 2 2011 157 167
2. E.A. Rakha, and I.O. Ellis Triple-negative/basal-like breast cancer: review Pathology 41 1 2009 40 47
3. S.K. Pal, B.H. Childs, and M. Pegram Triple negative breast cancer: unmet medical needs Breast Cancer Res Treat 125 3 2011 627 636
4. J. Haberland, J. Bertz, B. Görsch, R. Dölle, and B.M. Kurth Future cancer incidents in Germany Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49 5 2006 459 467
5. E. Marubini, L. Mariani, and B. Salvadori Results of a breast cancer surgery trial compared with observational data from routine practice Lancet 347 9007 1996 1000 1003
6. C. Schmoor, M. Olschewski, and M. Schumacher Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies Stat Med 5 3 1996 263 271
7. C. Mayers, T. Panzarella, and I.F. Tannock Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma Cancer 91 12 2001 2246 2257
8. V.H. Murthy, H.M. Krumholz, and C.P. Gross Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 22 2004 2720 2726
9. H.A. Tejeda, S.B. Green, and E.L. Trimble Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials J Natl Cancer Inst 88 12 1996 812 816
10. S.D. Fossa, and E. Skovlund Selection of patients may limit the generalizability of results from cancer trials Acta Oncol 41 2 2002 131 137
11. German Cancer Society. Benchmarkingbericht Brustkrebszentren. < http://www.onkozert.de/downloads/bz-allgemeiner-benchmarking2011(110517).pdf >.
12. L.J. Schouten, J.J. Jager, and P.A. van den Brandt Quality of cancer registry data: a comparison of data provided by clinicians with those of registrations personnel Br J Cancer 68 5 1993 974 977
13. R. Wolters, A.C. Regierer, and L. Schwentner A comparison of international breast cancer guidelines-do the national guidelines differ in treatment recommendations? Eur J Cancer 48 1 2012 1 11
14. Kreienberg R, Kopp I, Albert U, et al. Interdisciplinary S3 guideline for diagnosis and therapy of breast cancer in women. German cancer society 2008.
15. L.H. Schwamm, G.C. Fonarow, and M.J. Reeves Get with guidelines-stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack Circulation 119 1 2008 107 115
16. A. Wöckel, C. Kurzeder, and V. Geyer Effects of guideline adherence in primary breast cancer-A 5 year multi-center cohort study of 3976 patients Breast 19 2010 120 127
17. M.E. Hamaker, W.H. Schreurs, J.M. Uppelschoten, and C.H. Smorenburg Breast cancer in the elderly: retrospective study on diagnosis and treatment according to national guidelines Breast J 15 2009 26 33
18. L. Schwentner, R. Wolters, M.B. Wischnewsky, R. Kreienberg, and A. Wöckel Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients Breast 21 2 2012 171 177
19. L. Schwentner, R. Wolters, and K. Koretz Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival-a retrospective multi-centre cohort study Breast Cancer Res Treat 132 3 2012 1073 1080
20. K. Hancke, M.D. Denkinger, and J. König Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study Ann Oncol 21 4 2010 748 753
21. M.L. Janssen-Heijnen, H.A. Maas, and V.E. Lemmens The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001 Ned Tijdschr Geneeskd 149 30 2005 1686 1690
22. A. DeMichele, M. Putt, Y. Zhang, J.H. Glick, and S. Norman Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients Cancer 97 9 2003 2150 2159
23. P.S. Craft, J.M. Buckingham, and J.E. Dahlstrom Variation in the management of early breast cancer in rural and metropolitan centres: implications for the organisation of rural cancer services Breast 19 5 2010 396 401
24. N. Hebert-Croteau, J. Brisson, J. Latreille, M. Rivard, N. Abdelaziz, and G. Martin Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with nodal negative breast cancer J Clin Oncol 22 2004 3685 3693
25. A. Goldhirsch, W.C. Wod, R.D. Gelber, A.S. Coates, B. Thürlimann, and H.J. Senn Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 7 2007 1133 1144